Ads
related to: phases of clinical trials
Search results
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 20 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating ...
...Announces Picankibart (IBI112) Achieved Primary Endpoints in a Phase 3 Clinical Trial in Treating...
WRBL Columbus· 2 days agoCLEAR-1 is global the first Phase 3 registration study in IL-23p19 class that reported over 80% of subjects achieved PASI 90 after 16 weeks of& ...
IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies
Clinical Trials Arena via Yahoo Finance· 21 hours agoIn January, IGC Pharma announced the dosing of the first patient at ClinCloud, a new clinical...
Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab...
WROC Rochester· 6 days agoCPS<5. PRINCETON, N.J. and SUZHOU, China, May 23, 2024 /PRNewswire/ -- Transcenta Holding Limited...
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 7 days agoAdlai Nortye has dosed the first subject in the Phase II ARTEMIS clinical trial of palupiprant...
Invizius completes Phase I trial of dialysis priming product H-Guard
Clinical Trials Arena via Yahoo Finance· 7 days agoIn a June 2023 announcement, Invizius said that the study enables them to stratify the patient...
GeoVax to Present at BIO International Convention 2024
Digital Journal· 19 hours agoAbout GeoVax GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel therapies and vaccines for solid tumor cancers and many of the ...
Insmed stock target lifted on positive trial results By Investing.com
Investing.com· 13 hours agoThis adjustment follows the recent successful outcome of the ASPEN Phase 3 clinical trial. The ...
Halia Therapeutics to Participate at BIO International Convention and The European Hematology...
The Herald Journal· 20 hours agoPreliminary safety, efficacy, and biomarker data from the ongoing Phase II trial evaluating HT-6184 in MDS patients will be presented at the EHA 2024 Hybrid Congress.
Verona prepares for anticipated US launch of ensifentrine for COPD in Q3 2024
Pharmaceutical Technology via Yahoo Finance· 19 hours agoThe involvement of two optimistic agents to tackle symptoms and exacerbations as a fixed-dose...